Arcapta

Arcapta is a prescription medication used long-term to prevent breathing difficulties (wheezing, cough, chest tightness and shortness of breath) caused by chronic obstructive pulmonary disease (COPD). Arcapta belongs to a group of medications called long acting beta agonists (LABA). It works by helping the muscles in your lungs to stay relaxed, opening up the airways, making it easier to breathe.

Arcapta is a prescription medication used in adults to prevent symptoms of chronic obstructive pulmonary disease (COPD) such as wheezing, cough, chest tightness and shortness of breath. COPD is a lung disease that includes both chronic bronchitis and emphysema.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

The recommended Arcapta dose for the treatment of chronic obstructive pulmonary disease (COPD) is one 75 mcg capsule inhaled into the lungs using the Neohaler device once daily.

WARNING: ASTHMA-RELATED DEATH

Long-acting beta2-adrenergic agonists (LABA) increase the risk of asthma-related death. Data from a large placebo-controlled US study that compared the safety of another long-acting beta2-adrenergic agonist (salmeterol) or placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of LABA, including Arcapta, the active ingredient in Arcapta inhaler. The safety and efficacy of Arcapta inhaler in patients with asthma have not been established. Arcapta inhaler is not indicated for the treatment of asthma.

Arcapta can cause serious side effects, including:

• serious allergic reactions including rash, hives, swelling of the tongue, lips and face, difficulties in breathing or swallowing. Call your healthcare provider or get emergency medical care if you get any symptoms of a serious allergic reaction.
• sudden shortness of breath that may be life-threatening
• fast or irregular heartbeat (palpitations)
• increased blood pressure
• chest pain
• low blood potassium (which may cause symptoms of muscle spasm, muscle weakness or abnormal heart rhythm)
• high blood sugar

People with asthma who take long-acting beta2 adrenergic-agonist (LABA) medicines, such as Arcapta, have an increased risk of death from asthma problems.

It is not known if LABA medicines, such as Arcapta, increase the risk of death in people with chronic obstructive pulmonary disease (COPD).

• Get emergency medical care if:
  • breathing problems worsen quickly
  • you use your rescue inhaler medicine, but it does not relieve your breathing problems.

Do not use Arcapta if you:

• have asthma
• have had an allergic reaction to Arcapta 

Arcapta can cause serious side effects. See “Drug Precautions” section.

Common side effects include:

• runny nose
• cough
• sore throat
• headache
• nausea

Tell your healthcare provider about any side effect that bothers you or that does not go away. 

These are not all the side effects with Arcapta. Ask your healthcare provider or pharmacist for more information.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Tell your healthcare provider about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take:

• diuretics such as furosemide (Lasix), hydrochlorothiazide (HydroDiuril), metolazone (Zaroxolyn) and others
• beta blockers such as atenolol (Tenormin), carvedilol (Coreg), metoprolol (Lopressor, Toprol XL), propranolol (Inderal) and others
• antidepressants such as notriptyline (Pamelor), and MAO inhibitors
• other long-acting beta agonists such as formoterol (Foradil, Perforomist), salmeterol (Serevent) and others
• oral steroids such as prednisone (Deltasone), dexamethasone (Decadron, Dexone) methylprednisolone (Medrol) and others
• QT-prolonging medications 

This is not a complete list of Arcapta drug interactions. Ask your healthcare provider or pharmacist for more information.

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Arcapta falls into category C. There are no well-done studies that have been done in humans with Arcapta. But in animal studies, pregnant animals were given this medication, and the babies did not show any medical issues related to this medication.

It is not known if Arcapta crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Arcapta.

Indacaterol contains lactose (milk sugar) and a small amount of milk proteins. It is possible that allergic reactions may happen in patients who have a severe milk protein allergy.

Do not swallow indacaterol capsules. Indacaterol capsules should always be used with the Neohaler inhaler only.

Always use the new Neohaler inhaler that is provided with each new prescription.

Indacaterol does not relieve sudden symptoms of COPD. Always have a rescue inhaler medicine with you to treat sudden symptoms. If you do not have a rescue inhaler medicine, call your healthcare provider to have one prescribed for you.

Call your health care provider or get emergency medical care right away if your breathing problems worsen with indacaterol.